About HGHAX
Hartford Healthcare Fund Class A is an actively managed mutual fund that primarily targets the global healthcare sector. Its core purpose is to seek long-term capital appreciation by investing at least 80% of its assets in equity securities of health care-related companies worldwide. The fund’s portfolio incorporates a diversified mix of subsectors within healthcare, including pharmaceuticals, biotechnology, medical products, health services, managed health care, and emerging health-related technologies.
Managed by Wellington Management, the fund utilizes fundamental research to select companies considered leaders or innovators in their fields. Its holdings span across various market capitalizations, with a strong focus on industry giants but also exposure to mid- and small-cap firms, ensuring a broad representation of healthcare advancements. The fund’s top holdings typically include well-known companies like Eli Lilly and UnitedHealth Group, reflecting its emphasis on established players with significant market influence.
In the broader market, Hartford Healthcare Fund Class A plays a significant role for investors seeking concentrated exposure to the healthcare industry, a sector known for its resilience and potential for innovation-driven growth. The fund’s strategy aims to capitalize on global demographic trends, medical innovation, and evolving healthcare delivery models.
Fund Family Hartford Mutual Funds
Category Health
Performance Rating Average
Risk Rating Average
Stock Exchange Nasdaq
Ticker Symbol HGHAX
Share Class Class A
Index S&P Composite 1500 Health Care TR
HGHAX had a total return of 18.66% in the past year, including dividends. Since the fund's
inception, the average annual return has been 10.43%.
